The future of clinically tested and proven medical cannabis
PlantEXT is developing and commercializing the world’s most effective medical cannabis formulations for the treatment of Inflammation. PlantEXT has entered into a strategic partnership with the State of Israel’s Agricultural Research Organization (“ARO”) to develop and commercialize a treatment for Inflammatory Bowel Diseases, including Crohn’s and Colitis.
PlantEXT conducts pre-clinical studies in collaboration with ARO and at PlantEXT’s independent dedicated research facilities in Tel Aviv, focusing on unique combinations of cannabinoids that create synergistic anti-inflammatory activity and result in new genetic pathways targeted for the treatment of inflammation-related conditions.
Brands: PlantEXT Ltd.